Daniel Regan

Assistant professor

Colorado State University

United States

Research Interests

Explore related searches

Professors in United States Professors in Immunology Immunology professors in United States

Contact this professor

Get a free first email built on one of their papers, ready for you to edit and send yourself.

About

Dr. Daniel Regan is an Assistant Professor at Colorado State University, USA. His research focuses on the intersection of oncology and tissue engineering, as evidenced by his recent publications on osteosarcoma, rotator cuff repair technologies, and canine cancer models. He employs innovative techniques such as nanofiber technology and immune characterization to enhance understanding and treatment outcomes in veterinary medicine.

Articles (11)

Year:

2025

Year:

2024

Year:

2024

Year:

2023

Year:

2022

Year:

2022

Year:

2022

Year:

2021

Year:

2021

Year:

2021

Year:

2021

Collaborators (6)

Douglas Thamm

Professor of Oncology

Colorado State University

UNITED STATES

View details

Dawn Duval

UNITED STATES

View details

Kirk McGilvray

UNITED STATES

View details

Sangeeta Rao

Associate Professor

Colorado State University

UNITED STATES

View details

Eileen Hackett

Colorado State University

UNITED STATES

View details

Stewart Ryan

Senior Lecturer / Head of small animal surgery service

University of Melbourne

AUSTRALIA

View details

ApplyKite TwinLearns as you apply

Make your next move.

Prepare your application

Review drafts before you send them.

Daniel Regan

Research Interests

Explore related searches

Contact this professor

About

Articles (11)

Osteosarcoma Exosome Priming of Primary Human Lung Fibroblasts Induces an Immune Modulatory and Protumorigenic Phenotype

Biomechanical Enhancement in Rotator Cuff Repairs: The Impact of Innovative Nanofiber Technology

Immunohistochemical and transcriptomic characterization of T and myeloid cell infiltrates in canine malignant melanoma

Biphasic Interpositional Allograft for Rotator Cuff Repair Augmentation Is Safe in an Ovine Model

Characterizing the molecular and immune landscape of canine bladder cancer

Losartan Blocks Osteosarcoma-Elicited Monocyte Recruitment, and Combined With the Kinase Inhibitor Toceranib, Exerts Significant Clinical Benefit in Canine Metastatic Osteosarcoma

Rotator cuff repair using a bioresorbable nanofiber interposition scaffold: a biomechanical and histologic analysis in sheep

Outcome and prognosis for canine appendicular osteosarcoma treated with stereotactic body radiation therapy in 123 dogs

Canine Non-Angiogenic, Non-Myogenic Splenic Stromal Sarcoma: a Retrospective Clinicopathological Analysis and Investigation of Podoplanin as a Marker of Tumour Histogenesis

Role of Periostin Expression in Canine Osteosarcoma Biology and Clinical Outcome

Evaluation of Myogenin and MyoD1 as Immunohistochemical Markers of Canine Rhabdomyosarcoma

Collaborators (6)

Douglas Thamm

Dawn Duval

Kirk McGilvray

Sangeeta Rao

Eileen Hackett

Stewart Ryan

Make your next move.